Prostate Cancer - Results from #60

Prostate Imaging after Focal Ablation (PI-FAB): A Proposal for a Scoring System for Multiparametric MRI of the Prostate After Focal Therapy. May 23, 2023

Conditional survival of patients with low-risk prostate cancer: Temporal changes in active surveillance permanence over time. May 23, 2023

Development, multi-institutional external validation, and algorithmic audit of an artificial intelligence-based Side-specific Extra-Prostatic Extension Risk Assessment tool (SEPERA) for patients undergoing radical prostatectomy: a retrospective cohort stu May 23, 2023

Test-retest repeatability of organ uptake on PSMA-targeted 18 F-DCFPyL PET/CT in patients with prostate cancer. May 23, 2023

18 F-sodium fluoride positron emission tomography quantitation of bone metastases in African American and non-African American men with metastatic prostate cancer. May 23, 2023

Management of Prostate Cancer in Older Adults. May 22, 2023

Protocol of a multicentre randomised controlled trial assessing transperineal prostate biopsy to reduce infectiouscomplications. May 22, 2023

Guidelines for genetic testing in prostate cancer: a scoping review. May 22, 2023

Predictive value of kallikrein forms and β-microseminoprotein in blood from patients with evidence of detectable levels of PSA after radical prostatectomy. May 22, 2023

Impact of a negative confirmatory biopsy on risk of disease progression among men on active surveillance for prostate cancer. May 22, 2023

Effects of In-office Dispensing by Single-specialty Urology Practices on Management of Advanced Prostate Cancer. May 22, 2023

Methylation status of various gene loci in localized prostate cancer: Novel biomarkers for diagnostics and biochemical recurrence. May 19, 2023

Triplet Therapy in Metastatic Castrate Sensitive Prostate Cancer (mCSPC)-A Potential New Standard of Care. May 19, 2023

Diagnostic Impact of Dual-Time PET/CT with 68Gallium-PSMA in Prostate Cancer and 68Gallium-DOTATOC in Neuroendocrine Tumors. May 19, 2023

Real-World Treatment Patterns Among French Patients With Metastatic Castration-Resistant Prostate Cancer Under Abiraterone or Enzalutamide. May 19, 2023

A Retrospective Multicenter Analysis of the Incidence of Bone-Only Disease at PSMA PET/CT in Castration Resistant Prostate Cancer Patients. May 19, 2023

ExoDx prostate test as a predictor of outcomes of high-grade prostate cancer - an interim analysis. May 18, 2023

Lutetium-177 PSMA for the treatment of metastatic castrate resistant prostate cancer: a systematic review. May 18, 2023

Metastatic Castration-Resistant Prostate Cancer, Immune Checkpoint Inhibitors, and Beyond. May 18, 2023

Outcomes of Second-Line Therapies in Patients With Metastatic de Novo and Treatment-Emergent Neuroendocrine Prostate Cancer: A Multi-Institutional Study. May 18, 2023

Page 4 of 1305